Alnylam Pharmaceuticals Inc — institutional ownership

54 funds reported holding Alnylam Pharmaceuticals Inc in their latest 13F filings, worth $504M in total (CUSIP 02043QAB3).

Largest holders

1. STEELHEAD PARTNERS LLC — $78.2M
2. BNP PARIBAS FINANCIAL MARKETS — $50.9M
3. Boussard & Gavaudan Investment Management LLP — $40.8M
4. Alberta Investment Management Corp — $30.1M
5. BOUSSARD & GAVAUDAN GESTION SAS — $29.7M
6. DeepCurrents Investment Group LLC — $28.9M
7. Nuveen Asset Management, LLC — $27.6M
8. BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $22.5M
9. FMR LLC — $20.6M
10. MANUFACTURERS LIFE INSURANCE COMPANY, THE — $16.5M